Paper
Changes in membrane biophysical properties induced by the Budesonide/Hydroxypropyl-β-cyclodextrin complex.
Published Oct 1, 2017 · A. D. dos Santos, J. Bayiha, Gilles Dufour
Biochimica et biophysica acta. Biomembranes
23
Citations
0
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Non-RCTAnimal Study
Study Snapshot
The budesonide/Hydroxypropyl--cyclodextrin complex reduces inflammation in COPD patients by altering membrane fluidity, permeability, and cholesterol-enriched domains, potentially affecting inflammation pathways.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
—
···
—
···
—
···
—
···
—
···
—
···
—
···
—
···
Citations
—
···
—
···
—
···
—
···
—
···
—
···
—
···
—
···